New 'killer' immunotherapy shows promise in attacking hard-to-treat cancers - Impartial Reporter

Trials show the drug redirects the body’s own natural killer immune cells to target tumour cells.

A new killer immunotherapy treatment is showing early promise in attacking cancers that are hard to treat.Researchers at the Institute of Cancer Research (ICR), London, and the Royal Marsden NHS Foun… [+3897 chars]

full article...